Diplomat Pharmacy (DPLO) Tops Q1 EPS by 5c

Diplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.23, $0.05 better than the analyst estimate of $0.18. Revenue for the quarter came in at $995.9 million versus the consensus estimate of $982.87 million.

For earnings history and earnings-related data on Diplomat Pharmacy (DPLO) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• JPMorgan Upgrades ArcelorMittal (MT:NA) (MT) to Neutral
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance